GSK 269962 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier Pagecis-(Z)-Flupentixol dihydrochloride is a dopamine receptor antagonist, antipsychotic, neuroleptic agent.
More Information Supplier Pagecis-(Z)-Flupentixol dihydrochloride is a dopamine receptor antagonist, antipsychotic, neuroleptic agent.
More Information Supplier Pagecis-(Z)-Flupentixol dihydrochloride is a dopamine receptor antagonist, antipsychotic, neuroleptic agent.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageGSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageAmpalex is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator
More Information Supplier Page